Claims for Patent: 8,741,959

Summary for Patent: 8,741,959

Title:	Paracetamol for parenteral administration
Abstract:	The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 .mu.S cm.sup.-1.
Inventor(s):	Dasberg; David (Bad Homburg, DE), Achleitner; Georg (Graz, AT), Aichholzer; Christiane (Graz, AT)
Assignee:	Fresenius Kabi Deutschland GmbH (Bad Homburg, DE)
Application Number:	13/262,650
Patent Claims:	1. An aqueous pharmaceutical composition in the form of an infusion solution consisting essentially of water, paracetamol, a non-ionic isotonicizing agent, and cysteine, wherein the composition has an electrical conductivity of at most 200 .mu.S cm.sup.-1 wherein the composition does not contain any buffering agent, any C1-C6-alkanols, and any polyethylene glycol. 2. The composition according to claim 1, wherein the composition has a buffer capacity .beta. of at most 5.0 mmol l.sup.-1 pH.sup.-1. 3. The composition according to claim 1, wherein it has a pH in the range from 5.0 to 7.0. 4. The composition according to claim 1, wherein the nonionic isotonicizing agent is a sugar alcohol. 5. The composition according to claim 1, wherein the proportion by weight of the nonionic isotonicizing agent is greater than the proportion by weight of paracetamol. 6. The composition according to claim 1, wherein the composition has an osmolarity of at least 0.25 osmol/l.sup.-1. 7. The composition according to claim 1, wherein the composition contains virtually no salt. 8. The composition according to claim 1, wherein the paracetamol is present in a concentration of 10.0.+-.5.0 g l.sup.-1. 9. The composition according to claim 1, wherein the content of paracetamol after storage at 60.degree. C. for 4 weeks is at least 99.0% of the paracetamol originally contained in the composition. 10. The composition according to claim 1, wherein the composition is present in ready-to-use form. 11. The composition according to claim 1, wherein the composition has an osmolarity of at most 0.36 osmol/l.sup.-1. 12. The composition according to claim 1, wherein the infusion solution is formulated for intravenous infusion over a period of time of 2 minutes to 24 hours. 13. The composition of claim 1, wherein the composition has an electrical conductivity of at most 100 .mu.Scm.sup.-1. 14. The composition of claim 1, wherein the composition has an electrical conductivity of at most 70 .mu.Scm.sup.-1. 15. The composition of claim 1, wherein the composition has an electrical conductivity of at most 50 .mu.Scm.sup.-1. 16. The composition of claim 1, wherein the isotonicizing agent is mannitol. 17. The composition of claim 1, wherein the composition contains 10 g/liter paracetamol and no more than 36.7 g/liter mannitol. 18. The composition according to claim 1, wherein it contains no salt. 19. An aqueous pharmaceutical composition in the form of an infusion solution consisting of water, paracetamol, a non-ionic isotonicizing agent, and cysteine, wherein the composition has an electrical conductivity of at most 200 .mu.S cm.sup.-1. 20. The composition of claim 18, wherein the composition has an electrical conductivity of at most 100 .mu.Scm.sup.-1. 21. The composition of claim 18, wherein the composition has an electrical conductivity of at most 70 .mu.Scm.sup.-1. 22. The composition of claim 18, wherein the composition has an electrical conductivity of at most 50 .mu.Scm.sup.-1. 23. The composition of claim 18, wherein the isotonicizing agent is mannitol. 24. The composition of claim 23, wherein the composition contains 10 g/liter paracetamol and no more than 36.7 g/liter mannitol.